Mirae Asset Global Investments Co., Ltd. Trans Medics Group, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$70.86 - $89.93 $120,462 - $152,881	-1,700 Reduced 11.38%	13,240 $978,000
Q3 2023 Oct 26, 2023	BUY	$53.47 - $96.07 $90,899 - $163,319	1,700 Added 12.84%	14,940 $817,000
Q4 2022 Feb 09, 2023	BUY	$39.08 - $64.29 $76,323 - $125,558	1,953 Added 17.3%	13,240 $817,000
Q3 2022 Nov 10, 2022	BUY	$31.56 - $55.75 $356,217 - $629,250	11,287 New	11,287 $471,000

357

29.6M

399K

154K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $4.42B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.